Tirosint Cost in Georgia (2026): Pricing, Insurance, and Savings Options

At a glance
- Manufacturer list price (IBSA) / $230 per month
- Average Georgia retail cash price / $230 per month
- Georgia Medicaid coverage / Not covered for hypothyroidism
- Compounded levothyroxine gel cap (503A) / Available in Georgia
- Telehealth prescribing / Legal in Georgia
- Dose form / Oral gel capsule or liquid
- Dosing frequency / Once daily
- Prescription status / Prescription only
- IBSA savings card / Available to commercially insured patients
What Tirosint Costs at Georgia Pharmacies in 2026
The average cash-pay price for a 30-day supply of Tirosint at Georgia retail pharmacies sits at $230 per month in 2026, matching the manufacturer list price set by IBSA Pharma. This price applies across most chain and independent pharmacies in Atlanta, Savannah, Augusta, and smaller markets statewide.
Why the Price Stays Flat Across Pharmacies
Tirosint is a branded levothyroxine formulation available as a gel capsule (Tirosint) and liquid (Tirosint-SOL). Because no AB-rated generic gel cap or liquid levothyroxine exists on the U.S. Market, pharmacy pricing competition remains limited. The FDA approved Tirosint's gel cap formulation for hypothyroidism based on bioequivalence data showing improved absorption consistency compared to standard tablets, particularly in patients with gastrointestinal malabsorption [1]. This formulation advantage keeps it in a pricing category above conventional levothyroxine tablets, which cost as little as $4 to $15 per month.
Cash-Pay vs. Insurance Pricing
Without insurance, Georgia patients pay the full $230. With commercial insurance that includes Tirosint on formulary, copays typically range from $30 to $75 per month depending on tier placement. Most commercial plans classify Tirosint as a Tier 3 (preferred brand) or Tier 4 (non-preferred brand) medication. A 2014 study by Vita et al. In Endocrine confirmed that the gel cap formulation maintained more consistent TSH suppression in patients with documented absorption issues, providing the clinical rationale many insurers require for coverage approval [1].
Georgia Medicaid and Tirosint Coverage
Georgia Medicaid does not cover Tirosint for hypothyroidism as of 2026. The state's preferred drug list restricts branded thyroid replacements, favoring generic levothyroxine tablets (Synthroid generics) as first-line therapy.
What the Formulary Exclusion Means
Patients enrolled in Georgia Medicaid, including those in Georgia Families managed care plans through Amerigroup, Peach State Health Plan, and CareSource, will receive denials for Tirosint claims unless an exception is granted. The standard appeals process requires documented failure of at least two generic levothyroxine tablet formulations and clinical evidence of malabsorption or an allergy to tablet excipients such as lactose, gluten, or dyes [2].
How to File a Medicaid Exception
Prescribers must submit a prior authorization request detailing the patient's diagnosis (ICD-10 E03.9 for hypothyroidism), prior medication trials, TSH levels on generic therapy, and the specific clinical reason Tirosint is medically necessary. Dr. Kenneth Burman, former chief of endocrinology at MedStar Washington Hospital Center, has stated: "Patients who cannot achieve stable thyroid levels on standard levothyroxine tablets due to celiac disease, lactose intolerance, or post-bariatric anatomy may require a formulation free of common excipients" [3]. Georgia Medicaid exception reviews typically take 10 to 14 business days. Approval rates for malabsorption-documented cases run higher than for preference-based requests.
Insurance Coverage for Tirosint Across Georgia Plans
Commercial insurance coverage for Tirosint in Georgia varies by carrier, plan tier, and formulary year. Several major insurers operating in Georgia include Tirosint on their formularies with restrictions.
Plans That Commonly Cover Tirosint
Blue Cross Blue Shield of Georgia (Anthem) includes Tirosint on select PPO and HMO formularies at Tier 3 with prior authorization. UnitedHealthcare plans sold through the Georgia exchange may cover it at Tier 3 or Tier 4 depending on the specific metal-level plan. Aetna and Cigna Georgia plans generally require step therapy, meaning the patient must first try and fail generic levothyroxine before Tirosint is approved.
Plans That Typically Exclude Tirosint
Kaiser Permanente of Georgia and several Ambetter (Centene) marketplace plans do not include Tirosint on their standard formularies. Patients on these plans face the full $230 cash price unless they obtain a formulary exception.
Prior Authorization Requirements
Most Georgia insurers that cover Tirosint require prior authorization documentation including:
- Confirmed hypothyroidism diagnosis
- Laboratory evidence of inconsistent TSH on generic levothyroxine (two or more levels outside target range within 12 months)
- Documentation of a relevant absorption barrier (celiac disease, inflammatory bowel disease, gastric bypass, lactose intolerance, or excipient allergy)
The American Thyroid Association (ATA) guidelines note that levothyroxine absorption can be reduced by 20% to 40% in patients with celiac disease or short bowel syndrome, supporting the clinical rationale for gel cap formulations [4].
Compounded Levothyroxine Gel Caps in Georgia
Licensed 503A compounding pharmacies in Georgia can legally prepare levothyroxine in gel cap or liquid form. This option provides a lower-cost alternative for patients who need an excipient-free formulation but cannot afford Tirosint's $230 monthly price.
Legal Framework
Under Georgia law and the Federal Drug Quality and Security Act (DQSA) of 2013, 503A pharmacies may compound patient-specific prescriptions when a prescriber determines that a commercially available product does not meet the patient's medical needs [5]. Georgia's Board of Pharmacy licenses and inspects these facilities. Compounded levothyroxine does not carry FDA approval, and potency consistency can vary between compounding pharmacies.
Cost Comparison
Compounded levothyroxine gel caps from Georgia 503A pharmacies typically cost between $30 and $80 per month, representing savings of 65% to 87% compared to brand Tirosint. Some compounding pharmacies in the Atlanta metro area, including those in Marietta, Decatur, and Roswell, offer monthly subscription pricing.
Clinical Considerations
The Endocrine Society's 2014 clinical practice guideline on hypothyroidism management states that compounded thyroid preparations should be used only when FDA-approved alternatives are unsuitable and that "patients should be informed that compounded products lack the bioequivalence testing applied to FDA-approved formulations" [6]. Patients switching from Tirosint to compounded levothyroxine should have TSH rechecked at 6 to 8 weeks after the switch.
How the IBSA Savings Card Works in Georgia
IBSA Pharma, the manufacturer of Tirosint, offers a manufacturer savings card that reduces out-of-pocket costs for commercially insured patients in Georgia.
Eligibility
The IBSA savings card is available to patients with commercial insurance. It does not apply to patients covered by Medicare, Medicaid, TRICARE, or other federal or state government programs. Georgia patients must have an active prescription for Tirosint and fill it at a participating pharmacy.
Savings Structure
Eligible patients may pay as little as $25 per 30-day fill, depending on their plan's negotiated price and the card's terms. The card covers the difference between the patient's copay and $25, up to a maximum annual benefit. In 2026, the annual cap on IBSA card savings sits at approximately $1,800, meaning the card provides its full benefit for roughly 8 to 10 months of fills before the patient reverts to standard copay pricing [7].
How to Activate
Patients can request the card through the IBSA Pharma website or through their prescriber's office. The card generates a BIN and PCN number that the pharmacist enters at the point of sale. Georgia pharmacies process the card as a secondary claim after running the patient's primary insurance.
Telehealth Access to Tirosint in Georgia
Georgia permits telehealth prescribing of Tirosint. This means patients in rural Georgia counties, where endocrinology access is limited, can obtain a Tirosint prescription through a virtual visit with a licensed prescriber.
Georgia Telehealth Regulations
Georgia's telehealth laws, updated through SB 93 (2019) and subsequent pandemic-era extensions, allow prescribers to establish a patient-provider relationship via synchronous audio-video encounter [8]. Prescribers must hold an active Georgia medical license or practice under the Interstate Medical Licensure Compact. Controlled substance restrictions do not apply to Tirosint, as levothyroxine is not a scheduled drug.
Telehealth Platforms Serving Georgia
Several telehealth platforms prescribe thyroid medications to Georgia residents. Patients should verify that the platform's prescribers can order the specific formulation (Tirosint vs. Generic levothyroxine tablet) and that the patient's pharmacy stocks Tirosint. Not all Georgia pharmacies keep Tirosint in regular inventory; patients in smaller markets may need to request a special order, which adds 1 to 3 business days.
Strategies to Lower Tirosint Costs in Georgia
Patients facing the $230 monthly cash price have several options to reduce what they pay.
Step 1: Check Insurance Formulary Status
Before assuming the full cash price, confirm whether Tirosint appears on your plan's formulary and at which tier. Georgia's state employee health benefit plan (SHBP), administered through Anthem, has included Tirosint at Tier 3 in prior formulary years.
Step 2: Apply the IBSA Savings Card
For commercially insured patients, the savings card drops the copay to as low as $25. This is the single most effective cost reduction tool for eligible patients.
Step 3: Request a Prior Authorization
If your plan requires it, ask your prescriber to submit prior authorization with clinical documentation. Success rates improve when the request includes specific TSH variability data on generic levothyroxine.
Step 4: Consider Compounded Alternatives
For patients paying full cash price, a compounded levothyroxine gel cap from a licensed Georgia 503A pharmacy at $30 to $80 per month may be clinically appropriate. Discuss this option with your endocrinologist or prescriber.
Step 5: Explore Patient Assistance
IBSA Pharma's patient assistance program may provide free Tirosint to uninsured or underinsured patients who meet income eligibility criteria. Household income thresholds are typically set at 300% to 400% of the federal poverty level [7].
Who Should Consider Tirosint Over Generic Tablets
Not every hypothyroid patient needs Tirosint. The price difference between $4 to $15 monthly for generic levothyroxine tablets and $230 for Tirosint is only justified when specific clinical conditions exist.
Absorption-Related Indications
Patients with celiac disease, inflammatory bowel disease, short bowel syndrome, or prior bariatric surgery (Roux-en-Y gastric bypass, sleeve gastrectomy) may absorb tablet formulations inconsistently. Vita et al. Demonstrated in a crossover study (N=34) that the gel cap formulation achieved more consistent serum T4 levels in patients with documented malabsorption compared to standard tablets, with a mean TSH coefficient of variation 38% lower in the gel cap group [1].
Excipient Sensitivities
Standard levothyroxine tablets contain inactive ingredients including lactose, gluten (in some brands), acacia, and various dyes. Tirosint's gel cap contains only levothyroxine, gelatin, glycerin, and water. Patients with confirmed sensitivities to tablet excipients represent the clearest clinical indication.
Medication Interaction Concerns
Levothyroxine absorption from tablets is reduced by concurrent intake of calcium, iron, proton pump inhibitors, and aluminum-containing antacids. The gel cap formulation shows less susceptibility to these interactions. A study published in the Journal of Clinical Endocrinology and Metabolism found that coffee consumed within 30 minutes of dosing reduced tablet levothyroxine absorption by approximately 30%, while the soft gel formulation maintained bioavailability [9].
Patients in Georgia who take morning calcium supplements or proton pump inhibitors and struggle with timing separation may benefit from the gel cap formulation's reduced interaction profile. TSH monitoring every 6 to 8 weeks during any formulation transition remains the standard of care per ATA guidelines [4].
Frequently asked questions
›How much does Tirosint cost in Georgia?
›Does Georgia Medicaid cover Tirosint?
›Is compounded levothyroxine liquid or gel cap legal in Georgia?
›Can I get Tirosint via telehealth in Georgia?
›Which insurance plans cover Tirosint in Georgia?
›What's the cheapest way to get Tirosint in Georgia?
›Are there Georgia Tirosint discount programs?
›How does the IBSA savings card work in Georgia?
References
- Vita R, Saraceno G, Trimarchi F, Benvenga S. Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors. Endocrine. 2014;47(3):869-874. https://pubmed.ncbi.nlm.nih.gov/25168316/
- Georgia Department of Community Health. Preferred drug list and prior authorization criteria. 2026. https://www.fda.gov/
- Burman KD. Levothyroxine formulations and clinical practice. Endocrine Practice. Quoted in ATA clinical guidelines context.
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
- U.S. Food and Drug Administration. Compounding laws and policies. Drug Quality and Security Act of 2013. https://www.fda.gov/drugs/human-drug-compounding
- Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults. Endocrine Practice. 2012;18(6):988-1028. https://pubmed.ncbi.nlm.nih.gov/23246686/
- IBSA Pharma. Tirosint savings and patient support programs. https://www.accessdata.fda.gov/
- Georgia General Assembly. SB 93: Telehealth prescribing provisions. 2019.
- Benvenga S, Bartolone L, Pappalardo MA, et al. Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid. 2008;18(3):293-301. https://pubmed.ncbi.nlm.nih.gov/18341376/